Beyond the Strip: Innovations in Ketone Monitoring and Clinical Applications
Released On
July 21, 2025
Expires On
July 21, 2026
Media Type
Internet
Completion Time
15 minutes
Specialty
Diabetology, Endocrinology, Primary Care
Topics
Diabetes, Diabetic Ketoacidosis
Other modules in the Ketone Masterclass series
- Access: The DKA playbook: Applying Guidelines to Real-World Diagnosis
- Access: Pathways to Prevention: Understanding the Mechanisms Driving DKA
- Access: The Ketone Conversation: Removing Barriers and Rethinking Monitoring
Acknowledgement
This activity is supported by an independent educational grant from Abbott.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in ketone monitoring technology for patients with T2D.
Program Overview
Welcome to this Ketone Masterclass Module, which is a part of the larger CME-accredited program, Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management.
Developed by Dr. Eda Cengiz, MD, this masterclass examines current ketone monitoring technologies, the promise of continuous ketone monitoring, their integration with glucose control and future directions in care.
*Ready-to-use in the clinic: download the quick reference practice aid, summarizing this masterclass
---
This activity is part of the larger CME-accredited program Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management. Register for free to continue your Ketone Monitoring Masterclass journey or tune into conference highlights with program Director Dr. David Kerr. MBChB, DM, FRCP, FRCPE. © 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate current and emerging ketone monitors, including CKMs, and their recent clinical trial data
- Describe the most useful clinical scenarios to use various ketone monitoring systems
Faculty
Eda Cengiz, MD
Professor of Pediatrics
University of California San Francisco
San Francisco, CA, United States
Dr Eda Cengiz is a professor of pediatrics at the UCSF School of Medicine, Benioff UCSF professor in children’s health, and director of the UCSF Pediatric Diabetes Program.
Dr Cengiz has spearheaded diabetes-related clinical studies, focusing on methods to accelerate insulin action, diabetes technology, and closed-loop systems. She is a member of the NIH Initiative to Advance Pediatric Therapeutics Diabetes Core Group and served as an elected advisory board member for ISPAD. Dr Cengiz collaborates with pediatric diabetologists abroad and oversees multinational projects in diabetes research and management to promote the well-being of children with diabetes.
Dr Cengiz is a world-renowned scholar who has received numerous distinguished awards from premier academic institutions, including the Rosalind Franklin Society Special Award in Science, the Yale Clinical Center for Investigation Scholar Award, the Brown University W. Alpert Medical School Dean’s Excellence in Teaching Award, and the Yale School of Medicine Mae Gailani, MD, Faculty Teaching Award. She has been the institutional principal investigator of various diabetes-related clinical trials and has been awarded numerous research grants to conduct investigator-initiated studies. She has developed novel evidence-based guidelines for diabetes management and has served as keynote speaker for multiple scientific conferences domestically and abroad.
Joint Accreditation Statement
In support of improving patient care, this program has been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosure of Conflicts of Interest
Dr. Eda Cengiz:
- Employee: UCSF
- Grant/research support: Breakthrough T1D, Helmsley, NIH
- Speakers bureau/honoraria for non-CME: Novo Nordisk
- Consultant/advisory board: Adocia, Arecor, Eli Lilly, MannKind, Novo Nordisk, Portal Insulin, Tandem, Ypsomed
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Complete the pre-test.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes for healthcare professionals only. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]